TP53 and Alzheimer disease: We performed a series of mechanistic investigations assessing expression and distribution of VDR in AD brains and sought to determine the role of VDR/p53 complex formation in the pathogenesis of AD with the use of a chemical inhibitor of p53 in AD mice.